Exploring Dietary Supplements for Psoriasis Management: A Narrative Review
- 1Department of Dermatology and Venerology, Aalborg University Hospital, Aalborg, Denmark
Abstract
Psoriasis vulgaris is a common dermatological condition that significantly impacts patients’ quality of life and is associated with various comorbidities, such as psoriatic arthritis and cardiometabolic disease. Although several therapeutic modalities are currently available, patients continue to seek alternative treatments such as dietary supplements to alleviate their symptoms. This review examines the existing literature on a range of oral dietary supplements, including: coenzyme Q10, selenium, carotene, vitamin A, probiotics, vitamin B, vitamin C, vitamin D, vitamin E, phospholipids, fish oil/omega-3 fatty acids, curcumin, zinc, resveratrol, prebiotics, keratins, flavonoids, bakuchiol, cobber, phosphorus, arginine, magnesium, lecithin, luteolin, calcium, collagen, hyaluronic acid and quercetin. Across all studies, the supplements investigated are characterized by considerable heterogeneity, small sample sizes, and divergent methodologies and dosages. Consequently, current evidence is insufficient to recommend any dietary supplement routinely for psoriasis treatment. However, some supplements, particularly probiotics, omega-3 fatty acids, and curcumin, show promising trends that warrant further investigation. Clinicians should therefore discuss supplements on an individual basis, considering potential benefits, risks, and the limited evidence regarding their efficacy and safety.
Related
- Food-Derived Substances and Edible Chinese Medicinal Materials in Psoriasis Management: Potential, Evidence, and Perspectives-A Narrative Review.
- Improving allergic rhinitis symptoms through nutrition as an adjunct: a systematic review and meta-analysis on the efficacy of dietary supplements
- The Association Between Psoriasis and Cardiovascular Comorbidity: A Narrative Review
- Exploring the Molecular Mechanisms of Yinxieping Tablets in Psoriasis Treatment Based on Network Pharmacology, Bioinformatics, and Experimental Validation
- Less Is More: Cost-Effective Psoriasis Management via Disease-Driven Dosing of IL-17/IL-23 Inhibitors.
BibTeX
@article{pagh2026exploring,
title = {{Exploring Dietary Supplements for Psoriasis Management: A Narrative Review}},
author = {Priyanka Pagh and Sandra Hertz and Kasper F Hjuler},
journal = {Psoriasis: Targets and Therapy},
year = {2026},
month = oct,
doi = {10.2147/ptt.s598033},
url = {https://doi.org/10.2147/ptt.s598033},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Exploring Dietary Supplements for Psoriasis Management: A Narrative Review
AU - Priyanka Pagh
AU - Sandra Hertz
AU - Kasper F Hjuler
PY - 2026
DA - 2026/10/26
JO - Psoriasis: Targets and Therapy
DO - 10.2147/ptt.s598033
UR - https://doi.org/10.2147/ptt.s598033
AB - Psoriasis vulgaris is a common dermatological condition that significantly impacts patients’ quality of life and is associated with various comorbidities, such as psoriatic arthritis and cardiometabolic disease. Although several therapeutic modalities are currently available, patients continue to seek alternative treatments such as dietary supplements to alleviate their symptoms. This review examines the existing literature on a range of oral dietary supplements, including: coenzyme Q10, selenium, carotene, vitamin A, probiotics, vitamin B, vitamin C, vitamin D, vitamin E, phospholipids, fish oil/omega-3 fatty acids, curcumin, zinc, resveratrol, prebiotics, keratins, flavonoids, bakuchiol, cobber, phosphorus, arginine, magnesium, lecithin, luteolin, calcium, collagen, hyaluronic acid and quercetin. Across all studies, the supplements investigated are characterized by considerable heterogeneity, small sample sizes, and divergent methodologies and dosages. Consequently, current evidence is insufficient to recommend any dietary supplement routinely for psoriasis treatment. However, some supplements, particularly probiotics, omega-3 fatty acids, and curcumin, show promising trends that warrant further investigation. Clinicians should therefore discuss supplements on an individual basis, considering potential benefits, risks, and the limited evidence regarding their efficacy and safety.
SN - 2230-326X
ER -